EPRX earnings date and last-quarter result: last quarter miss, P/E -6.15. Updated 2026-07-23.
Eupraxia Pharmaceuticals (EPRX) Research Hub
Eupraxia Pharmaceuticals (EPRX) trades on NASDAQ, CA in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 6.85 USD (-0.29%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -6.15, market cap 0.22B. This hub links to the full technical, earnings and options research available for EPRX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, CA |
| Last close | 6.85 USD (-0.29%) |
| 52-week range | 5.72 USD – 9.21 USD |
| Trend regime | Range |
| 14-day RSI | 37.5 (Bearish) |
| Trailing P/E | -6.15 |
| Market cap | 0.22B |
| Dividend yield | 0.00% |
Available research for EPRX
Covered Call on EPRX: how it works, illustrative setup around the real 6.85 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on EPRX: how it works, illustrative setup around the real 6.85 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on EPRX: how it works, illustrative setup around the real 6.85 USD price, max profit/loss, breakeven and when to use it. Educational.
EPRX technical analysis: range, last 6.85 USD, RSI 37.5, 52w range 5.72 USD–9.21 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is EPRX in?
Eupraxia Pharmaceuticals (EPRX) is classified under Healthcare (Biotechnology), listed on NASDAQ, CA.
Is EPRX in an uptrend or downtrend?
As of 2026-10-26, EPRX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is EPRX's trailing P/E ratio?
EPRX's trailing P/E is -6.15, with a market cap of 0.22B. See the earnings research page for full valuation detail.